Continuous Glucose Monitor Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

Overview

The Continuous Glucose Monitor (CGM) market is experiencing substantial growth, projected to reach USD 3.5 billion by 2025, with a compound annual growth rate (CAGR) of approximately 6.5% from 2021 to 2025. This growth is driven by the rising prevalence of diabetes, technological advancements in CGM systems, and the growing awareness regarding diabetes management.

Market Size

In 2020, the global CGM market was valued at approximately USD 2.7 billion. As of 2025, experts predict that the market will expand to USD 3.5 billion. This growth can be attributed to an increasing diabetic population, estimated to reach over 537 million globally by 2025, alongside a shift toward more patient-friendly monitoring solutions.

Market Share & Trends Analysis

By Product Type

The CGM market is segmented into wearable devices and software solutions. The wearable devices segment currently holds about 80% of the total market share, with a projected growth rate of 5%-8% over the coming years. In contrast, the software segment, utilized for data analysis and trend monitoring, is expected to grow rapidly due to the integration of artificial intelligence and cloud-based technologies.

Key Players

The competitive landscape features several key players:

• DexCom
• Abbott Laboratories
• Medtronic
• Roche Diagnostics
• LifeScan
• Ascensia Diabetes Care
• Senseonics
• GlucoTrack
• Nemaura Medical
• A. Menarini Diagnostics

By Process

The market can further be segmented by the processes involved, which include traditional and advanced processes. Traditional CGMs, which operate on a basic algorithm, account for approximately 60% of the market share, while advanced CGMs leveraging machine learning technologies are anticipated to grow at a rate of 7%-10% per year.

By Application

The application segment of the market is divided into home and hospital use. Home applications dominate the market, holding around 70% of the share due to the rising trend of self-monitoring diabetes at home. The hospital segment, on the other hand, is expected to expand with a boost of 4%-6% CAGR as healthcare institutions increasingly implement CGMs for better patient management.

By End-Use

CGMs are commonly utilized in various end-use segments, predominantly by hospitals and clinics. In 2025, hospitals are expected to account for nearly 60% of the volume share, driven by the growing need for continual patient monitoring and real-time data analysis in clinical settings.

By Region

Regionally, North America holds the largest share of the CGM market due to high diabetes prevalence and greater adoption of advanced healthcare technologies, contributing around 40% to the market share. Europe follows with a share of about 30%, attributed to supportive programs for diabetes care and significant investments in healthcare innovation. The Asia-Pacific region is anticipated to witness the fastest growth, with a CAGR of 8%-10% from 2021 to 2025, propelled by increasing health awareness and expanding healthcare infrastructures.

Market News on Policy and Companies

Several recent regulatory developments have occurred within the CGM industry aimed at enhancing the safety and effectiveness of these devices. The FDA has introduced more stringent guidelines to ensure reliable performance in CGMs, which is expected to shape competitive strategies among major players. Additionally, companies such as DexCom and Abbott Laboratories have made significant strides in launching next-generation CGM systems, further solidifying their standing in the market.

Segment Forecasts (2025 - 2030)

Going forward, the CGM market is forecasted to continue its upward trajectory, with expectations of reaching USD 5 billion by 2030. The shift toward digital health solutions and smart technologies in diabetes management is likely to revolutionize traditional monitoring processes, leading to an average CAGR of 8%-11% over the next decade.

Conclusion

In summary, the Continuous Glucose Monitor market is poised for remarkable growth through 2025, driven by increasing diabetes prevalence worldwide, innovations in technology, and rising healthcare expenditures. Stakeholders, including manufacturers, healthcare providers, and patients, will benefit from the advancements in this field, leading to improved patient outcomes and enhanced quality of life for individuals managing diabetes.